RDA2
A
2
197378
131840
1026
1
262153
16
dat.pagliaro1992
787
4
13
54
1
1
1
2
2
2
3
3
4
4
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
25
25
26
26
16
54
262153
13
beta-blockers
262153
13
sclerotherapy
262153
7
control
262153
13
beta-blockers
262153
13
sclerotherapy
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
beta-blockers
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
262153
13
sclerotherapy
262153
7
control
13
54
2
9
13
12
13
13
4
4
20
30
1
11
7
10
18
31
2
11
8
2
4
0
3
22
5
30
5
6
3
9
11
31
19
9
17
26
10
29
12
14
0
3
13
14
31
23
20
19
3
12
3
5
6
2
13
54
43
42
41
68
73
72
20
16
116
111
30
49
53
53
85
89
51
51
23
25
18
19
35
36
56
53
16
18
23
22
49
46
53
60
53
60
71
69
41
41
21
20
33
35
143
138
55
51
13
16
21
28
22
24
1026
1
262153
5
names
16
4
262153
5
study
262153
3
trt
262153
2
xi
262153
2
ni
1026
1
262153
5
class
16
1
262153
10
data.frame
1026
1
262153
9
row.names
13
2
NA
-54
254
254
